An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection

Clinical trial NCT07495007 · COMPLETED

Trial details

NCT number: NCT07495007
Sponsor: Zi Diligence Biocenter
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalance Post-menopause

Start date: 2025-11-10
Primary completion: 2025-12-28
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.